GlassScriptPhysician profile
Francis Nott Bain
NPI 1629072608
$4,428.70
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,254 · 2020: $1,107 · 2021: $1,068.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $928.20 | 2019-2021 | |
| Pfizer INC. | $506.14 | 2019-2021 | |
| Amarin Pharma, INC. | $476.64 | 2019-2020 | |
| Esperion Therapeutics, INC. | $337.02 | 2020-2021 | |
| Allergan, INC. | $288.53 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.63 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $281.60 | 2019-2021 | |
| Lilly USA, LLC | $233.89 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $222.76 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $219.61 | 2019 | |
| Glaxosmithkline, LLC. | $143.41 | 2019-2021 | |
| Astellas Pharma US INC | $125.00 | 2019 | |
| Novo Nordisk INC | $96.08 | 2021 | |
| Edwards Lifesciences Corporation | $90.45 | 2019 | |
| Sanofi-Aventis U.S. LLC | $84.65 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $25.78 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $21.42 | 2021 | |
| Mannkind Corporation | $19.52 | 2020 | |
| Merck Sharp & Dohme LLC | $15.90 | 2020 | |
| Abbvie INC. | $14.84 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.63 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Bain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.